VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2020 | Breast cancer trends in 2021 and beyond

Komal Jhaveri, MD, FACP, Memorial Sloan Kettering Cancer Center, New York, NY, discusses future endeavors in the treatment of breast cancer, including triplet combination targeted therapies such as those evaluated in the SUMMIT trial (NCT01953926), as well as recent approvals of novel antibody-drug conjugates such as sacituzumab govitecan. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter